Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.

European Journal of Nuclear Medicine and Molecular Imaging
Bart de KeizerD J Kwekkeboom

Abstract

Receptor radionuclide therapy is a promising treatment modality for patients with neuroendocrine tumors for whom alternative treatments are limited. The aim of this study was to investigate the incidence of hormonal crises after therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-octreotate). All (177)Lu-octreotate treatments between January 2000 and January 2007 were investigated. Four hundred seventy-six patients with gastroenteropancreatic neuroendocrine tumors and three patients with metastatic pheochromocytoma were included for analysis. Four hundred seventy-nine patients received a total of 1,693 administrations of (177)Lu-octreotate. Six of 479 patients (1%) developed severe symptoms because of massive release of bioactive substances after the first cycle of (177)Lu-octreotate. One patient had a metastatic hormone-producing small intestinal carcinoid; two patients had metastatic, hormone-producing bronchial carcinoids; two patients had vasoactive intestinal polypeptide-producing pancreatic endocrine tumors (VIPomas); and one patient had a metastatic pheochromocytoma. With adequate treatment, all patients eventually recovered. Hormonal crises after (177)Lu-octreotate therapy occ...Continue Reading

Associated Clinical Trials

References

Jan 1, 1988·Annals of the New York Academy of Sciences·S R BloomJ M Polak
Nov 7, 1985·The New England Journal of Medicine·L K KvolsC G Moertel
Jan 1, 1995·The Medical Clinics of North America·S S Werbel, K P Ober
Dec 1, 1993·The Annals of Thoracic Surgery·R Karmy-Jones, E Vallières
Jan 28, 1998·International Anesthesiology Clinics·D J Vaughan, M D Brunner
Sep 16, 1998·Lancet·M E CaplinA K Burroughs
Apr 28, 2000·Intensive Care Medicine·M JanssenJ R Roelandt
Oct 18, 2000·Chest·J R KizerM G St John Sutton
Oct 5, 2001·European Journal of Nuclear Medicine·D J KwekkeboomE P Krenning
Jan 16, 2002·Current Opinion in Oncology·Wouter W de Herder, Steven W J Lamberts
Dec 19, 2002·Journal of Clinical Gastroenterology·Houssam Al Kharrat, Howard Taubin
Nov 25, 2003·Annals of Clinical Biochemistry·Cornelis J M LipsJo W M Höppener
May 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K ObergB Wiedenmann
Jan 20, 2005·The British Journal of Dermatology·H K BellN J E Wilson
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dik J KwekkeboomEric P Krenning
Jun 5, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Edgar J RollemanMarion de Jong

❮ Previous
Next ❯

Citations

Mar 6, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Lisa BodeiGiovanni Paganelli
Feb 8, 2013·European Journal of Nuclear Medicine and Molecular Imaging·L BodeiJohn J Zaknun
Apr 8, 2010·Journal of Medical Case Reports·Suzana Manxhuka-KerliuLabinot Shahini
Oct 26, 2011·Endocrine-related Cancer·Jaap J M TeunissenEric P Krenning
Jul 30, 2014·Thoracic Surgery Clinics·Lisa BodeiGiovanni Paganelli
Mar 6, 2012·European Journal of Nuclear Medicine and Molecular Imaging·B L R KamD J Kwekkeboom
Jul 18, 2014·PET Clinics·Lisa BodeiGiovanni Paganelli
Dec 24, 2015·International Journal of Molecular Sciences·Jonas AhlstedtBo Åkerström
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Dik J KwekkeboomEric P Krenning
Jan 18, 2011·Annales d'endocrinologie·F IllouzV Rohmer
Feb 2, 2010·Seminars in Nuclear Medicine·Dik J KwekkeboomEric P Krenning
Mar 15, 2016·Best Practice & Research. Clinical Endocrinology & Metabolism·Tessa BrabanderDik J Kwekkeboom
Jun 9, 2011·Clinical Endocrinology·Wouter W de HerderRichard A Feelders
Sep 23, 2008·Expert Opinion on Pharmacotherapy·I M ModlinB I Gustafsson
Apr 16, 2013·Best Practice & Research. Clinical Gastroenterology·Hendrik BergsmaDik J Kwekkeboom
Oct 24, 2015·Journal of Gastrointestinal Cancer·Cory Allen Gaiser, Natasha Dhawan
May 23, 2015·Archives of Endocrinology and Metabolism·Alina Coutinho Rodrigues FeitosaAdelina Sanches
Jul 15, 2017·Expert Opinion on Drug Safety·A FaggianoA Colao
Jun 28, 2018·AJR. American Journal of Roentgenology·Erik S Mittra
Jan 13, 2012·Neuroendocrinology·Esther I van VlietDik J Kwekkeboom
Dec 20, 2018·The Journal of Clinical Endocrinology and Metabolism·Wouter T ZandeeWouter W de Herder
Jun 3, 2009·Nature Reviews. Endocrinology·Martijn van EssenDik J Kwekkeboom
May 1, 2019·AJR. American Journal of Roentgenology·A Tuba KendiRathan M Subramaniam
Aug 31, 2019·Current Treatment Options in Oncology·Grace Kong, Rodney J Hicks
Feb 5, 2019·Current Radiopharmaceuticals·Shahad AlsadikAdil Al-Nahhas
Aug 30, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Lin-Jie Guo, Cheng-Wei Tang
Apr 21, 2020·World Journal of Gastroenterology : WJG·Estephany Abou Jokh CasasÁlvaro Ruibal Morell
Mar 17, 2020·Current Treatment Options in Oncology·Shagufta ShaheenPamela L Kunz
Feb 22, 2017·Current Oncology Reports·Mauro Cives, Jonathan Strosberg
Jun 27, 2018·Nuclear Medicine and Molecular Imaging·Keunyoung Kim, Seong-Jang Kim
Jul 16, 2020·Journal of Clinical Medicine·Maria Isabel Del Olmo-GarcíaJuan-Francisco Merino-Torres
Oct 13, 2020·Nuclear Medicine Communications·Tara HaddadReza Vali
Dec 10, 2020·Clinical Endocrinology·Simon J RyderDavid A Pattison
Apr 22, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tessa BrabanderDik J Kwekkeboom
Dec 18, 2020·Seminars in Interventional Radiology·Evan D Lehrman, Nicholas Fidelman
Jul 3, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Thomas A HopeJonathan R Strosberg
Jun 3, 2021·AJR. American Journal of Roentgenology·Sara SheikhbahaeiLilja B Solnes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.